Part of the Medicine and Health Sciences Commons

Works by S. A. Mortensen in Medicine and Health Sciences

2011

Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients. Am J Transplant 2010;10:1228–1237, C. da Cunha-Bang, M. Iversen, S. A. Mortensen, A. Rasmussen, H. Sengeløv, S. S. Sørensen, J. Lundgren
Maura Iversen

Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients, C. Da Cunha-Bang, M. Iversen, S. A. Mortensen, A. Rasmussen, H. Sengeløv, S. S. Sørensen, J. Lundgren
Maura Iversen

2010

132: Everolimus Introduction with CNI Minimization Significantly Improves Renal Function in Thoracic Transplant Recipients: A Scandinavian Multicenter, Randomized Study, L. Gullestad, B. Rundqvist, S. A. Mortensen, H. Eiskjaer, G. C. Riise, Lena Mared, O. Bjortuft, Björn Ekmehag, K. Jansson, S. Simonsen, E. Gude, H. Fagertun, D. Solbu, M. Iversen
Maura Iversen